Literature DB >> 8911550

Effect of ketanserin on 5-hydroxytryptamine-induced constriction in isolated, perfused canine basilar arteries exposed to blood.

T Tsuji1, D A Cook.   

Abstract

The blocking effect of ketanserin, a 5-hydroxytryptamine (5-HT)2 receptor antagonist, was examined on responses to intra-luminal 5-HT or potassium chloride (KCl) in isolated and perfused canine basilar arteries before and after extraluminal whole blood by means of the stainless-steel cannula inserting method. Four hours after the application of blood, the constriction to 5-HT was significantly enhanced, while that to KCl was significantly attenuated. The absolute value in the decrease of perfusion pressure for the 5-HT-induced constriction sensitive to ketanserin was much greater after the blood application than that before the application. It is suggested that the augmentation of cerebrovascular responses to 5-HT in the early stage immediately after subarachnoid haemorrhage (SAH) might be mediated by 5-HT2 receptors at least in part. This early constrictor mechanism may be implicated in the aetiology of the following late stage of cerebral vasospasm after SAH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8911550     DOI: 10.1007/bf01412316

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  32 in total

Review 1.  Serotonergic receptor subtypes and vascular reactivity.

Authors:  J M Van Nueten; J E Leysen; F de Clerck; P M Vanhoutte
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

2.  Early changes in rabbit cerebral artery reactivity after subarachnoid hemorrhage.

Authors:  M Debdi; J Seylaz; R Sercombe
Journal:  Stroke       Date:  1992-08       Impact factor: 7.914

3.  Impairment of endothelium-dependent relaxation in human basilar artery after subarachnoid hemorrhage.

Authors:  K Hatake; I Wakabayashi; E Kakishita; S Hishida
Journal:  Stroke       Date:  1992-08       Impact factor: 7.914

4.  Vasoconstrictor expression of human platelet-vessel wall interactions: inhibition by the Ca2+ entry blocker flunarizine.

Authors:  J M Van Nueten; W De Ridder; L Van Gorp; F De Clerck
Journal:  Eur J Pharmacol       Date:  1987-01-20       Impact factor: 4.432

5.  Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

Authors:  J M Van Nueten; P A Janssen; J Van Beek; R Xhonneux; T J Verbeuren; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

6.  Nimodipine and chronic vasospasm in monkeys: Part 2. Pharmacological studies of vessels in spasm.

Authors:  C Krueger; B Weir; M Nosko; D Cook; S Norris
Journal:  Neurosurgery       Date:  1985-02       Impact factor: 4.654

7.  Time course of vasospasm in man.

Authors:  B Weir; M Grace; J Hansen; C Rothberg
Journal:  J Neurosurg       Date:  1978-02       Impact factor: 5.115

8.  Vasoconstrictor mechanism of 5-hydroxytryptamine in isolated and perfused canine basilar arteries.

Authors:  T Tsuji; S Chiba
Journal:  Arch Int Pharmacodyn Ther       Date:  1987-03

9.  Effects of calcium antagonists on isolated bovine cerebral arteries: inhibition of constriction and calcium-45 uptake induced by potassium or serotonin.

Authors:  W W Wendling; C Harakal
Journal:  Stroke       Date:  1987 May-Jun       Impact factor: 7.914

10.  The 5-hydroxytryptamine antagonist ketanserin inhibits the vasoconstrictor activity of per-operative CSF, from subarachnoid haemorrhage patients, on isolated tissues.

Authors:  P C Tagari; A H Kaye; P J Teddy; M Schachter; C B Adams; D J Boullin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-03       Impact factor: 10.154

View more
  1 in total

Review 1.  Inflammatory Pathways Following Subarachnoid Hemorrhage.

Authors:  Kevin Min Wei Khey; Alec Huard; Sherif Hanafy Mahmoud
Journal:  Cell Mol Neurobiol       Date:  2019-12-05       Impact factor: 5.046

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.